BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29858127)

  • 21. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.
    Frietze KM; Lijek R; Chackerian B
    Expert Rev Vaccines; 2018 Nov; 17(11):959-966. PubMed ID: 30300019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential for vaccine development against chlamydial infection and disease.
    Brunham RC; Zhang DJ; Yang X; McClarty GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it justifiable to perform screening tests for Chlamydia trachomatis in pregnant women?
    Perlik M; Drews K; Pieńskowski W
    Med Wieku Rozwoj; 2005; 9(1):117-25. PubMed ID: 16082073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
    Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G
    Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
    Hafner LM; Timms P
    Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
    Poston TB; Darville T
    Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of vaccine preparation for urogenital Chlamydiosis prophylaxis].
    Koroleva EA; Zigangirova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):114-23. PubMed ID: 22308743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to murine chlamydial genital infection.
    Morrison RP; Caldwell HD
    Infect Immun; 2002 Jun; 70(6):2741-51. PubMed ID: 12010958
    [No Abstract]   [Full Text] [Related]  

  • 29. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward".
    Zhong G; Brunham RC; de la Maza LM; Darville T; Deal C
    Vaccine; 2019 Nov; 37(50):7346-7354. PubMed ID: 29097007
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccines for sexually transmitted infections.
    Rupp RE; Stanberry LR; Rosenthal SL
    Pediatr Ann; 2005 Oct; 34(10):818-20, 822-4. PubMed ID: 16285635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMMUNOLOGY. A Chlamydia vaccine on the horizon.
    Brunham RC
    Science; 2015 Jun; 348(6241):1322-3. PubMed ID: 26089500
    [No Abstract]   [Full Text] [Related]  

  • 34. Chlamydia trachomatis.
    Sheff B
    Nursing; 2001 Jan; 31(1):71. PubMed ID: 11216250
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies to Variable Domain 4 Linear Epitopes of the
    Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of a Chlamydia trachomatis T cell Vaccine.
    Karunakaran KP; Yu H; Foster LJ; Brunham RC
    Hum Vaccin; 2010 Aug; 6(8):676-80. PubMed ID: 20523121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia trachomatis Infection in minority adolescent women: a public health challenge.
    Cooksey CM; Berggren EK; Lee J
    Obstet Gynecol Surv; 2010 Nov; 65(11):729-35. PubMed ID: 21375789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and follow-up of genital chlamydial infection by direct methods and by detection of serum IgG, IgA and secretory IgA.
    Fresse AS; Sueur JM; Hamdad F
    Indian J Med Microbiol; 2010; 28(4):326-31. PubMed ID: 20966563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for chlamydia.
    Low N; Harbord RM; Egger M; Sterne JA; Herrmann B
    Lancet; 2005 Apr 30-May 6; 365(9470):1539. PubMed ID: 15866303
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
    Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.